Remdesivir

New Delhi: The supply of Remdesivir — a key drug in treating COVID-19 — is much more than the demand in the country at present, Minister of State for Chemicals and Fertilizers Mansukh Mandaviya said on Saturday. The minister also informed…

New Delhi: India has increased the production of Remdesivir by nearly three times. It is now producing to 1.05 crore vials per month, stated the  Minister of State for Chemicals and Fertilisers Mansukh Mandaviaya on Tuesday. From 37 lakh…

New Delhi: The Centre has started importing Remdesivir from other countries to ease out the shortage of the vital drug against COVID-19 in the country. The first consignment of 75,000 vials will reach India on Friday, according to a…

New Delhi: Injectable drug Remdisivir, which is used for the treatment of COVID-19, is going off the shelves at a time when the second wave of COVID-19 is at a peak in the country. There have been reports of the shortage of antiviral drug.…

New Delhi: The production of Remdesivir will be ramped up substantially in India and its price will be reduced as well. The decisions were taken following two-day deliberations between Union Minister of State For Ports, Shipping and…

New Delhi: Remdesivir is to be given only to serious COVID-19 patients in hospitals and is not to be used in home settings, said the Centre on Tuesday, asking doctors to ensure "rational and judicious" use of anti-viral drug. "Remdesivir is…

Pune: Anti-viral drug Remdesivir, which was thus far being prescribed only to hospitalized coronavirus patients if they developed breathing problems, may be considered to treat COVID-positive patients who are in home isolation. This was…

New Delhi: Union Health Minister Dr Harsh Vardhan has said that the Centre is inspecting the coronavirus reinfection cases, along with every novel aspect of the virus. The minister assured the country that incidence of reinfection is not…

Remdesivir has been launched under the brand name Remdac in the Indian market. Meant to treat patients suffering from severe symptoms of COVID-19, it will be priced at Rs 2,800 per 100 mg vial. Remdac is the most economical Remdesivir…

Ahmedabad: If everything goes according to plan, Zydus Cadila will complete trials for its COVID-19 vaccine by February or March next year, company chairman Pankaj Patel said on Friday and added that they could produce up to 100 million…